Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran
- PMID: 35154609
- PMCID: PMC8817755
Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran
Abstract
Aim: This study aimed to identify the risk factors of metabolic (dysfunction)-associated fatty liver disease (MAFLD) among adults in northeastern Iran.
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and hepatic manifestation of metabolic syndrome that threatens global public health. Recently, MAFLD has been proposed as a new terminology updated from NAFLD and diagnosed based on modified criteria.
Methods: A nested case-control study was performed on the participants of the first phase of the Persian Sabzevar Cohort Study (PSCS), a survey that was conducted in northeastern Iran and enrolled 4,242 participants aged 35-70 years. In total, 968 MAFLD cases and 964 controls adjusted for age and sex were recruited. Data including demographic, lifestyle, anthropometric, biochemical, sleep pattern, and dietary intake information was collected.
Results: The mean (SD [standard deviation]) age of participants was 49.2 (8.8) years, and 39.9% of the participants were males. The prevalence of MAFLD was 22.8% (95% CI [confidence interval] 19.2 - 26.3%). Increased body mass index (BMI) (OR [odds ratios] 5.51, 95% CI 2.73 - 11.10), waist circumference (WC) (OR 1.85, 95% CI 1.44 - 2.38), blood concentrations of triglycerides (TG) (OR 1.10, 95% CI 1.06 - 1.15), total cholesterol (TC) (OR 1.02, 95% CI 1.003 - 1.04), and alanine aminotransferase (AST) (OR 1.10, 95% CI 1.05 - 1.16) were significantly associated with an increased risk of the MAFLD (p-value <0.05). Furthermore, the odds of MAFLD risk was 43% higher in subjects who slept ≤ 5 hrs/day than those with ≥ 7 hrs per day of sleep (OR 1.43; 95% CI 1.07 - 1.92, p-value = 0.01).
Conclusion: In this study, it was found that MAFLD was best predicted by BMI, WC, and serum levels of TG, total cholesterol, and AST. Sleeping ≤ 5hrs/day compared to ≥ 7hrs/day was associated with an increased risk of MAFLD.
Keywords: Iranians; Metabolic-associated fatty liver disease; Non-alcoholic fatty liver disease; Risk factors.
©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.World J Hepatol. 2023 Aug 27;15(8):985-1000. doi: 10.4254/wjh.v15.i8.985. World J Hepatol. 2023. PMID: 37701916 Free PMC article.
-
Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study.J Nutr. 2022 Feb 8;152(2):559-567. doi: 10.1093/jn/nxab391. J Nutr. 2022. PMID: 34791370
-
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.J Diabetes Metab Disord. 2022 Jan 11;21(1):97-107. doi: 10.1007/s40200-021-00941-w. eCollection 2022 Jun. J Diabetes Metab Disord. 2022. PMID: 35673435 Free PMC article.
-
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?Clin Mol Hepatol. 2021 Apr;27(2):257-269. doi: 10.3350/cmh.2021.0067. Epub 2021 Mar 22. Clin Mol Hepatol. 2021. PMID: 33751877 Free PMC article. Review.
-
Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis.Front Nutr. 2022 Jun 17;9:906511. doi: 10.3389/fnut.2022.906511. eCollection 2022. Front Nutr. 2022. PMID: 35782947 Free PMC article. Review.
Cited by
-
Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.Liver Int. 2024 Feb;44(2):389-398. doi: 10.1111/liv.15787. Epub 2023 Nov 16. Liver Int. 2024. PMID: 37971775
-
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease.Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139650. doi: 10.1177/20420188221139650. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 36533185 Free PMC article. Review.
-
Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.Front Endocrinol (Lausanne). 2022 Sep 16;13:1004855. doi: 10.3389/fendo.2022.1004855. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187093 Free PMC article.
References
-
- Loomba R, Sanyal AJ. The global NAFLD epidemic. Nature reviews Gastroenterol Hepatol. 2013;10:686–90. - PubMed
-
- Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2021:S1542–3565(21)00208-1. - PubMed
-
- Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47–S64. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous